3,0
22 giu 2021
Dipendente attuale
Philadelphia, PA
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Slowly starting to bring its business into 2021 thinking. Enjoyable people. Gumption gets you somewhere.
Svantaggi
Extreme complexity kills speed and nimbleness at GSK : R&D chief does not understand his own business nor cares to - thus needed enterprise, structural, leadership changes are not made: clarity and decisiveness are missing in R&D. Recommend to start over to build anew from the ground up